These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10639512)

  • 1. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells.
    Brinkman A; van der Flier S; Kok EM; Dorssers LC
    J Natl Cancer Inst; 2000 Jan; 92(2):112-20. PubMed ID: 10639512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
    van der Flier S; Brinkman A; Look MP; Kok EM; Meijer-van Gelder ME; Klijn JG; Dorssers LC; Foekens JA
    J Natl Cancer Inst; 2000 Jan; 92(2):120-7. PubMed ID: 10639513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of BCAR4, a novel oncogene causing endocrine resistance in human breast cancer cells.
    Godinho M; Meijer D; Setyono-Han B; Dorssers LC; van Agthoven T
    J Cell Physiol; 2011 Jul; 226(7):1741-9. PubMed ID: 21506106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The substrate domain of BCAR1 is essential for anti-estrogen-resistant proliferation of human breast cancer cells.
    Brinkman A; de Jong D; Tuinman S; Azaouagh N; van Agthoven T; Dorssers LC
    Breast Cancer Res Treat; 2010 Apr; 120(2):401-8. PubMed ID: 19412734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AND-34/BCAR3, a GDP exchange factor whose overexpression confers antiestrogen resistance, activates Rac, PAK1, and the cyclin D1 promoter.
    Cai D; Iyer A; Felekkis KN; Near RI; Luo Z; Chernoff J; Albanese C; Pestell RG; Lerner A
    Cancer Res; 2003 Oct; 63(20):6802-8. PubMed ID: 14583477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How is tamoxifen's action subverted?
    Jordan VC
    J Natl Cancer Inst; 2000 Jan; 92(2):92-4. PubMed ID: 10639501
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
    Wallez Y; Riedl SJ; Pasquale EB
    J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.
    van der Flier S; Chan CM; Brinkman A; Smid M; Johnston SR; Dorssers LC; Dowsett M
    Int J Cancer; 2000 Sep; 89(5):465-8. PubMed ID: 11008210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.
    Dorssers LC; van Agthoven T; Brinkman A; Veldscholte J; Smid M; Dechering KJ
    Breast Cancer Res; 2005; 7(1):R82-92. PubMed ID: 15642172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
    Kumbrink J; Kirsch KH
    Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of BCAR3 by a random search for genes involved in antiestrogen resistance of human breast cancer cells.
    van Agthoven T; van Agthoven TL; Dekker A; van der Spek PJ; Vreede L; Dorssers LC
    EMBO J; 1998 May; 17(10):2799-808. PubMed ID: 9582273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
    Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
    Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
    Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
    J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell lines.
    van Agthoven T; Godinho MF; Wulfkuhle JD; Petricoin EF; Dorssers LC
    Int J Cancer; 2012 Nov; 131(9):1998-2007. PubMed ID: 22328489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene expression signature from human breast cancer cells with acquired hormone independence identifies MYC as a mediator of antiestrogen resistance.
    Miller TW; Balko JM; Ghazoui Z; Dunbier A; Anderson H; Dowsett M; González-Angulo AM; Mills GB; Miller WR; Wu H; Shyr Y; Arteaga CL
    Clin Cancer Res; 2011 Apr; 17(7):2024-34. PubMed ID: 21346144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pure antiestrogen, ICI 182,780, stimulates the growth of tamoxifen-resistant KPL-1 human breast cancer cells in vivo but not in vitro.
    Kurebayashi J; Otsuki T; Yamamoto S; Kurosumi M; Nakata T; Akinaga S; Sonoo H
    Oncology; 1998 Dec; 55 Suppl 1():23-34. PubMed ID: 9852399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AND-34/BCAR3 differs from other NSP homologs in induction of anti-estrogen resistance, cyclin D1 promoter activation and altered breast cancer cell morphology.
    Near RI; Zhang Y; Makkinje A; Vanden Borre P; Lerner A
    J Cell Physiol; 2007 Sep; 212(3):655-65. PubMed ID: 17427198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue.
    van der Flier S; van der Kwast TH; Claassen CJ; Timmermans M; Brinkman A; Henzen-Logmans SC; Foekens JA; Dorssers LC
    Int J Biol Markers; 2001; 16(3):172-8. PubMed ID: 11605729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT; Sarvilinna NS; Ylikomi TJ
    Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.